Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MET | P08581 | 20/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.42 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.42 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12489822 | 0.77 | MET (0.56) | METCYP2C9PDE3BPDE3APDE10A | |
| SCHEMBL23127952 | 0.77 | MET (0.48) | METCYP2C9PDE3BPDE3APDE10A | |
| SCHEMBL22475672 | 0.77 | CSF1R (0.41) | PDE10A | |
| SCHEMBL24591026 | 0.76 | MET (0.57) | METCYP2C9PDE3BPDE3APDE10A | |
| SCHEMBL12489857 | 0.76 | MET (0.80) | METCYP2C9PDE3BPDE3APDE10A | |
| SCHEMBL18462452 | 0.75 | MET (0.56) | METCYP2C9PDE3BPDE3APDE10A | |
| SCHEMBL16587147 | 0.75 | MET (0.60) | METCYP2C9PDE3BPDE3APDE10A | |
| SCHEMBL12487424 | 0.73 | MET (0.57) | METCYP2C9PDE3BPDE3APDE10A | |
| SCHEMBL12489232 | 0.72 | MET (0.56) | METCYP2C9PDE3BPDE3APDE10A | |
| SCHEMBL12489709 | 0.71 | MET (0.51) | METCYP2C9PDE3BPDE3APDE10A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3795573-B1 | CERTAIN TRIAZOLOPYRAZINES, COMPOSITIONS THEREOF AND METHODS OF USE THEREFOR | HUTCHISON MEDIPHARMA LTD (CN) | 2022-07-06 | — | — | EP | disclosed |
| EP-3511330-A1 | SYNTHETIC INTERMEDIATE USEFUL IN THE PREPARATION OF TRIAZOLOPYRIDINE C-MET INHIBITORS | Hutchison Medipharma Limited (CN) | 2019-07-17 | — | — | EP | disclosed |